Jian Rong, Chunyu Zhao, Ahmad F Chaudhary, Jiahui Chen, Yinlong Li, Xin Zhou, Zhendong Song, Zhenkun Sun, Yabiao Gao, Siyan Feng, Taoqian Zhao, Qi-Long Hu, Chongjiao Li, Achi Haider, Jimmy Patel, Chongzhao Ran, Hongjie Yuan, Steven H Liang: Radiosynthesis and evaluation of an 18F-labeled radioligand for imaging metabotropic glutamate receptor 3 with positron emission tomography. Am J Nucl Med Mol Imaging 2025;15(5):173-182. (Full text, PDF)
Yinlong Li, Xin Zhou, Zhendong Song, Taoqian Zhao, Jian Rong, Jiahui Chen, Chunyu Zhao, Qilong Hu, Xiaoyan Li, Chongjiao Li, Zhenkun Sun, Yabiao Gao, Jimmy S Patel, Ahmad Chaudhary, Hongjie Yuan, Steven H Liang: Radiosynthesis and evaluation of a carbon-11 labeled PET ligand for imaging of O-GlcNAcase. Am J Nucl Med Mol Imaging 2025;15(5):183-192. (Full text, PDF)
Monica Cheng, Umar Mahmood, Nathaniel D Mercaldo, Shadi A Esfahani, Thomas Ng, Xin Gao, Jason A Efstathiou, Pedram Heidari: Molecular tumor volume on PSMA PET/CT is an independent imaging biomarker associated with progression-free survival in patients with oligorecurrent prostate cancer. Am J Nucl Med Mol Imaging 2025;15(5):193-199. (Full text, PDF)
Fuhao Zhang, Xiang Li, Jingliang Zhang, Zhiyong Quan, Zefei Zhang, Tingting Han, Xiaoli Meng, Lingyu Ma, Xuebing Yu, Weijun Qin, Fei Kang: Performance of PRIMARY Score based on PSMA-PET imaging in suspected prostate cancer patients with different PSA ranges: a retrospective study. Am J Nucl Med Mol Imaging 2025;15(5):200-207. (Full text, PDF)
Steven H. Liang: PARP-targeted molecular imaging for noninvasive diagnosis and surgical guidance in basal cell carcinoma. Am J Nucl Med Mol Imaging 2025;15(5):208-211. (Full text, PDF)
Jimmy S. Patel, Runhong Li, Steven H. Liang: Visualizing T-cell activation: PET imaging of CXCL9 as a window into the tumor immune response. Am J Nucl Med Mol Imaging 2025;15(5):212-214. (Full text, PDF)
Steven H. Liang: DLL3-targeted immunoPET and radioimmunotherapy ligands. Am J Nucl Med Mol Imaging 2025;15(5):215-218. (Full text, PDF)
Steven H. Liang: From lutetium to terbium: a new era in PSMA-targeted radioligand therapy for mCRPC patients. Am J Nucl Med Mol Imaging 2025;15(5):219-222. (Full text, PDF)
